IP Library Granted Patent US 9,409,982
Granted Patent B2
US 9,409,982 · App. 14/520,528 · Granted Aug 9, 2016

Antibody composition-producing cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,409,982
App. No.
14/520,528
Granted
Aug 9, 2016
Kind
B2
Abstract

The present invention relates to a cell for the production of an antibody molecule such as an antibody useful for various diseases having high antibody-dependant cell-mediated cytotoxic activity, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.

Claims (8)

1. An animal cell containing a DNA encoding an antibody, wherein said animal cell is modified, by a modification, to exhibit a reduced amount, or an absence, of N-glycoside-linked sugar chains containing fucose linked through an α-1,6 linkage, and wherein said animal cell produces antibodies that do not contain fucose linked through an α-1,6 linkage,

wherein said modification causes a reduction in, or an absence of, at least one intracellular sugar nucleotide in said cell, said at least one intracellular sugar nucleotide being selected from the group consisting of: GDP-α4-keto-6-deoxymannose; GDP-α4-keto-6-deoxygalactose; and GDP-fucose.

2. The animal cell according to claim 1 , wherein said modification is the introduction into said cell, or the deletion from said cell, of an enzyme, said introduction or deletion causing a reduction in the amount, or an absence, of the at least one intracellular sugar nucleotide in said cell.

3. The animal cell according to claim 2 , wherein the enzyme is an enzyme which alters the structure of a substrate for an enzyme in a GDP-fucose synthesis pathway.

4. The animal cell according to claim 3 , wherein the enzyme in the GDP-fucose synthesis pathway is GDP-keto-6-deoxymannose 3,5-epimerase 4-reductase.

5. The animal cell according to claim 1 , wherein the antibodies produced by said cell that do not contain fucose linked through an α-1,6 linkage constitute 20% or more of the total antibodies produced by said cell.

6. The animal cell according to claim 5 , wherein the antibodies produced by said cell that do not contain fucose linked through an α-1,6 linkage constitute 50% or more of the total antibodies produced by said cell.

7. The animal cell according to claim 1 , wherein the animal cell is a CHO cell.

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →